hey Class im with u i know have known but not to much info on this mess board. not many people follow axgn
been following for about 3 years finally got in this past summer at around $2.50 avg. got 40k this has been looking very good lately . i put an order to buy 5k today for $3.50 at 11:00 this morn. i know it closed at 3:50
late in the day but i dont know if my order filled. i use a broker this is my stock not his he bought some. this is an under valued gem if this breaks 5 dollars watch out !! and my only hope is when they sell the company it at
7 - 8 bucks. IMO there is a strong possibility this company will be sold at some point down the road. and ill be there waiting
Sentiment: Strong Buy
Jill Schiaparelli CMO (Chief Marketing Officer) of Axogen, Inc. (NASDAQ: AXGN) and Dr. Shahrokh C. Bagheri, Chair of Oral and Maxillofacial surgery at Northside Hospital of Atlanta were Interviewed Live on 640WGST Talk Radio Atlanta's Health Tech Talk Live Hosted by Ben Chodor -- January 10, 2015 https://www.youtube.com/watch?v=8Cbgp2sEpWQ
Published on Jan 6, 2015
Jill Schiaparelli CMO (Chief Marketing Officer) of Axogen, Inc. (NASDAQ: AXGN) was Interviewed Live on 77WABC Radio "The Amilya Show" Hosted by Amilya Antonetti -- December 20, 2014
when they promote the Senior Vice President of Business Strategy and Marketing. This could mean they are happy with the stratgy and marketing results and, right now, this is what it's all about-- making a "paradigm shift in the peripheral nerve repair market". Axogen is on course to big revs. IMO!
Indicates confidence that burn rate not a problem as attendance at forums and sales begin to ramp. Execs have a lot of equity for pay so there's incentive there and insider activity is good. A while ago there were a lot less job openings. If they were not confident about more sales coming, they'd be conserving on the cash burn rate.
Today, from Zacks:
As of late, it has definitely been a great time to be an investor in AxoGen, Inc. (AXGN - Snapshot Report). The stock has moved higher by 21.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider AXGN’s recent earnings estimate revision activity. The company also reported 58% year-over-year growth in third quarter revenue on Nov 13. From this look, the company’s future is quite favorable; as AXGN has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.
AxoGen, Inc. ( AXGN ) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Although no particular reason has driven the uptrend, the stock has witnessed solid insider buying over the latter half of 2014. Reversing the recent trend of the company, the stock is now trading above the volatile price range of $36.32 to $41.24 in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate however moved higher over the same time frame, suggesting that more solid trading could be ahead for this stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
AxoGen currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Read more: http://www.nasdaq.com/article/axogen-inc-axgn-jumps-545-on-insider-buying-tale-of-the-tape-cm425152#ixzz3MMko9hJe
The golden cross is in and it blows through the 300DMA on huge volume. Bullish.
I think De Novo Ventures II LP, an AXGN beneficial owner, filed to sell 50 K shares on 12/10/14 but the demand for shares seems to be strong, chart looks real good and overall insider activity has been good..
Good future here. Momentum for the products is starting to accelerate, IMO.